Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

无锡洪汇新材料科技股份有限公司 关于取得专利证书的公告 本公司及全体董事保证本公告内容真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏。 无锡洪汇新材料科技股份有限公司（以下简称"洪汇新材"）于近日收到国家 知识产权局颁发的 1 项发明专利证书，具体情况如下： 证券代码：002802 证券简称：洪汇新材 公告编号：2025-031 上述专利的取得是公司坚持持续创新的成果，不会对公司生产经营产生重大 影响，但有利于公司进一步完善知识产权保护体系，发挥自主知识产权优势，促 进技术创新，提高公司的综合竞争能力，对公司的生产经营有积极影响。 特此公告。 无锡洪汇新材料科技股份有限公司 董 事 会 二〇二五年七月二日 | 序 | 专利 | 专利 | 专利名称 | 专利号 | 专利申请日 | 授权公告 | 证书号 | 有效 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | 类型 | 权人 | | | | 日 | | 期 | | 1 | 发明 专利 | 洪汇 新材 | 一种五金零件用 水性防护烤漆及 | ZL 2023 1 | 2023. ...

Group 1 - The announcement details the release of pledged shares by a major shareholder, Xiang Hongwei, who holds over 5% of the company's shares [1] - Xiang Hongwei has released 6,500,000 shares, which accounts for 15.62% of his total holdings and 3.57% of the company's total shares [1] - As of the announcement date, the total pledged shares held by the shareholder amount to 41,604,757 shares, representing 22.82% of his holdings [2] Group 2 - The announcement confirms that the company and its board guarantee the truthfulness and completeness of the information provided [1] - The release of shares occurred on June 20, 2025, and the company has documented the details of the pledge release [1][2] - The announcement serves as a formal notification to stakeholders regarding the changes in share pledges by a significant shareholder [1]

证券代码：002802 证券简称：洪汇新材 公告编号：2025-030 无锡洪汇新材料科技股份有限公司 关于公司持股 5%以上股东部分股份解除质押的公告 本公司及全体董事保证本公告内容真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏。 一、持股5%以上股东股份解除质押的基本情况 无锡洪汇新材料科技股份有限公司（以下简称"公司"）于近日收到持股5% 以上股东项洪伟先生的函告，获悉其持有的本公司的部分股份办理了解除质押的 手续，项洪伟先生股份解除质押的情况具体如下： | 股东名称 | 是否为控股 股东或第一 | 本次解除质 押股份数量 | 占其所持 股份比例 | 占公司总 股本比例 | 起始日 | | 解除日期 | | 质权人 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 大股东及其 | （股） | （%） | （%） | | | | | | | | 一致行动人 | | | | | | | | | | 项洪伟 | 否 | 6,500,000 | 15.62 | 3.57 | 2024 年 09 | | 2025 06 ...

General Principles - The rules are established to standardize company behavior and ensure shareholders can exercise their rights according to relevant laws and regulations [1][2] - The company must hold shareholder meetings in compliance with the law, ensuring the board of directors fulfills its responsibilities [1][2] Shareholder Meeting Types - Shareholder meetings are categorized into annual and temporary meetings, with annual meetings held within six months after the end of the previous fiscal year [1][2] - Temporary meetings must be convened within two months if circumstances arise that require them [1][2] Meeting Convening Procedures - If the company cannot convene a meeting within the specified timeframe, it must report to the local regulatory authority and the Shenzhen Stock Exchange [2] - Legal opinions must be obtained on the legality of the meeting's procedures, participant qualifications, and voting results [2][3] Proposals and Notifications - Proposals must fall within the scope of the shareholder meeting's authority and be clearly defined [5][6] - Shareholders holding more than 1% of shares can submit proposals at least ten days before the meeting [5][6] Voting and Decision-Making - Voting must be conducted in accordance with the rules, with each share carrying one vote, except for shares held by the company itself [8][10] - The results of the voting must be announced immediately after the meeting, and detailed records must be kept [14][15] Regulatory Compliance - The company must comply with all legal and regulatory requirements regarding the convening and conducting of shareholder meetings [16][17] - Any violations may result in disciplinary actions from regulatory authorities [16][17]

General Provisions - The company aims to protect the legal rights of the company, shareholders, employees, and creditors, and to regulate its organization and behavior according to relevant laws and regulations [1][2] - The company is established as a joint-stock limited company in Wuxi, with a registered capital of RMB 182.30199 million [2][3] - The company was approved by the China Securities Regulatory Commission for its initial public offering of 27 million shares on June 29, 2016 [1][3] Business Objectives and Scope - The company's business objectives emphasize customer supremacy, quality, technology, and strict management [3] - The business scope includes research and development, technical consulting, manufacturing, and sales of various chemical products and plastic products [3] Shares - The company issues shares in the form of stocks, with all shares being ordinary shares totaling 182.30199 million [4][5] - The issuance of shares follows principles of openness, fairness, and justice, ensuring equal rights for all shares of the same category [4][5] - The company may increase capital through various methods, including issuing shares to unspecified objects or existing shareholders [4][5] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, attend meetings, supervise the company, and transfer their shares [7][8] - Shareholders must comply with laws and the company's articles of association, and they are liable for their subscribed shares [11][12] - The company must maintain a shareholder register based on records from the securities registration and settlement institution [7][8] Shareholder Meetings - The company holds annual and temporary shareholder meetings, with specific procedures for calling and conducting these meetings [16][18] - Shareholders holding more than 10% of shares can request a temporary meeting, and the board must respond within a specified timeframe [18][19] - The company must provide legal opinions on the meeting's legality and ensure proper documentation of the meeting proceedings [21][24] Voting and Resolutions - Resolutions can be ordinary or special, with ordinary resolutions requiring a simple majority and special resolutions requiring two-thirds approval [26][27] - The company must ensure that all proposals are clearly stated and that shareholders are informed of their rights to vote and participate [21][26] - Meeting records must be maintained for ten years, documenting all proceedings and decisions made during the meetings [25][26]

Core Points - The document outlines the external guarantee system of Wuxi Honghui New Materials Technology Co., Ltd, aiming to regulate external guarantee behaviors, control risks, and protect the rights of shareholders and stakeholders [1][2][3] Group 1: General Principles - The external guarantee refers to the guarantees provided by the company and its subsidiaries for others, including guarantees, mortgages, pledges, and other forms of guarantees [1][2] - The company must ensure that the external guarantees are legal, prudent, mutually beneficial, and secure, with strict risk control [2] - The external guarantees are subject to unified management, requiring board or shareholder meeting approval before any contracts can be signed [2][3] Group 2: Guarantee Approval Process - The company must conduct thorough investigations into the creditworthiness and operational status of the guaranteed party before providing guarantees [6][7] - Guarantees exceeding 10% of the company's latest audited net assets or total assets require shareholder meeting approval [10][11] - The company can hire external professionals to assess risks associated with external guarantees as part of the decision-making process [11][12] Group 3: Management and Disclosure - The finance department is responsible for managing external guarantees, including credit investigations, documentation, and monitoring the financial status of guaranteed parties [13][14] - The company must disclose information regarding external guarantees in accordance with relevant regulations, including total guarantee amounts and any defaults by guaranteed parties [16][17] - Independent directors are required to provide special reports on the status of external guarantees in the annual report [17][18] Group 4: Responsibilities and Penalties - The company holds responsibility for ensuring compliance with the external guarantee system, with penalties for individuals who violate procedures or cause losses [44][45] - Any unauthorized signing of guarantee contracts by board members or management will lead to accountability measures [46][47] - The company must take necessary actions to recover losses from guaranteed parties who fail to meet their obligations [15][36]

Core Viewpoint - The document outlines the selection system for accounting firms at Wuxi Honghui New Materials Technology Co., Ltd, aiming to enhance audit quality and protect shareholder interests through a structured and regulated process [2][3]. Group 1: General Principles - The selection of accounting firms must comply with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [2]. - The company must not engage an accounting firm for annual audits before shareholder approval [2][3]. Group 2: Selection Criteria - Selected accounting firms must possess independent legal status and meet qualifications set by regulatory authorities [3]. - Firms must have a solid organizational structure, quality control systems, and a good reputation in the industry [3]. Group 3: Selection Procedures - The audit committee is responsible for proposing the selection of accounting firms and overseeing the audit process [3][4]. - The selection process must be competitive and transparent, utilizing methods such as public bidding and competitive negotiations [5][6]. Group 4: Evaluation Standards - Evaluation criteria for accounting firms include audit fees, qualifications, quality management, and risk management capabilities [6][7]. - Quality management must account for at least 40% of the evaluation score, while audit fees should not exceed 15% [6]. Group 5: Audit Fees and Duration - There is no maximum limit on audit fees unless specified in the selection documents, and any significant changes in fees must be disclosed [7][9]. - Audit partners cannot serve on the same company's audit for more than five consecutive years [8]. Group 6: Information Disclosure - The company must disclose information regarding the accounting firm, including service duration and audit fees, in annual reports [9]. - Any changes in accounting firms must be reported, including reasons for the change and communication with previous firms [9]. Group 7: Supervision and Penalties - The audit committee must monitor the selection process and report any violations of the selection criteria [12][13]. - Serious violations by accounting firms can lead to their disqualification from future audits [12][13].

Core Viewpoint - The company, Wuxi Honghui New Materials Technology Co., Ltd., has approved amendments to its Articles of Association and governance structure to enhance corporate governance and compliance with regulatory requirements [1][2]. Summary by Sections Board Meeting and Resolutions - The fifth board meeting was held on June 20, 2025, with all five directors present, and the meeting was deemed legal and effective [1]. - The board unanimously approved the proposal to amend the Articles of Association [2]. Amendments to Articles of Association - The amendments include improvements to general provisions, legal representative regulations, and the addition of sections for controlling shareholders and actual controllers, clarifying their responsibilities [2]. - A new section for the board's specialized committees was added, establishing an audit committee to exercise the statutory powers of the supervisory board [2]. - The independent directors' section was introduced, detailing their roles, independence, and responsibilities [2]. - A chapter on the party organization was added, affirming its legal status in corporate governance [2]. - The supervisory board section was removed, with its powers transferred to the audit committee [3]. Governance System Revisions - The board approved revisions to several governance documents, including the rules for shareholder meetings, board meetings, independent director work systems, external guarantee management, external investment management, related party transaction management, fundraising management, and accounting firm selection [4][5][6][7]. Board Restructuring - The company plans to conduct elections for the sixth board of directors due to changes in controlling shareholders and actual controllers [6][7]. - Three candidates for non-independent directors were nominated: Sheng Hanping, Xiang Hongwei, and Chen Yu [6]. - Two candidates for independent directors were nominated: Wu Changming and Wang Yang, with Wu needing to complete independent director training [8][10]. Upcoming Shareholder Meeting - The board approved the convening of the first extraordinary general meeting of shareholders in 2025 to vote on the proposed amendments and board elections [9].

无锡洪汇新材料科技股东有限公司 会计师事务所选聘制度 无锡洪汇新材料科技股份有限公司 会计师事务所选聘制度 (2025 年 6 月) 第一章 总 则 第一条 为规范无锡洪汇新材料科技股份有限公司（以下简称"公司"）选聘（含新 聘、续聘、改聘，下同）会计师事务所相关工作，提高审计工作和财务信息的质量，切实 维护股东利益，根据《中华人民共和国公司法》、《中华人民共和国证券法》、《深圳证 券交易所股票上市规则》、《国有企业、上市公司选聘会计师事务所管理办法》等法律法 规、规范性文件和《无锡洪汇新材料科技股份有限公司章程》（以下简称"《公司章程》"）， 结合公司实际情况，制定本制度。 第二条 本制度所称选聘会计师事务所，是指公司根据相关法律法规的要求，聘任会 计师事务所对财务会计报告发表审计意见、出具审计报告的行为。公司聘任会计师事务所 从事除财务会计报告审计之外的其他法定审计业务的，可以比照本制度执行。 第三条 公司聘用或解聘会计师事务所应当经董事会审计委员会（以下简称"审计委 员会"）审核后，提交董事会审议，并由股东会决定。公司不得在股东会审议通过前聘请 会计师事务所开展年度审计工作。 第四条 公司控股股东、实际 ...